Federation des caisses Desjardins du Quebec’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $146K | Buy |
|
|||||
|
2025
Q2 | $101K | Buy |
|
|||||
|
2025
Q1 | $62K | Sell |
|
|||||
|
2024
Q4 | $73.3K | Buy |
|
|||||
|
2024
Q3 | $46.1K | Sell |
|
|||||
|
2024
Q2 | $56.1K | Buy |
|
|||||
|
2024
Q1 | $70.3K | Buy |
|
|||||
|
2023
Q4 | $50.1K | Sell |
|
|||||
|
2023
Q3 | $40.9K | Hold |
|
|||||
|
2023
Q2 | $50.6K | Sell |
|
|||||
|
2023
Q1 | $42.7K | Buy |
|
|||||
|
2022
Q4 | $21.1K | Sell |
|
|||||
|
2022
Q3 | $55.1K | Buy |
|
|||||
|
2022
Q2 | $45.2K | Sell |
|
|||||
|
2022
Q1 | $52K | Sell |
|
|||||
|
2021
Q4 | $74.5K | Sell |
|
|||||
|
2021
Q3 | $116K | Sell |
|
|||||
|
2021
Q2 | $204K | Sell |
|
|||||
|
2021
Q1 | $157K | Buy |
|
|||||
|
2020
Q4 | $170K | Buy |
|
|||||
|
2020
Q3 | $83.9K | Sell |
|
|||||
|
2020
Q2 | $317K | Sell |
|
|||||
|
2020
Q1 | $1.07M | Buy |
|
|||||
|
2019
Q4 | $90.1K | Sell |
|
|||||
|
2019
Q3 | $64.4K | Hold |
|
|||||
|
2019
Q2 | $73.9K | Sell |
|
|||||
|
2019
Q1 | $57.2K | Sell |
|
|||||
|
2018
Q4 | $48.6K | Sell |
|
|||||
|
2018
Q3 | $192K | Sell |
|
|||||
|
2018
Q2 | $272K | Buy |
|
|||||
|
2018
Q1 | $50.3K | Buy |
|
|||||
|
2017
Q4 | $5.87K | Hold |
|
|||||
|
2017
Q3 | $4.47K | Sell |
|
|||||
|
2017
Q2 | $12.8K | Buy |
|
|||||
|
2017
Q1 | $14.1K | Buy |
|